Union City, CA, United States of America

Teresa Alejandra Trejo-Martin


 

Average Co-Inventor Count = 5.8

ph-index = 4

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2007-2013

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Teresa Alejandra Trejo-Martin

Introduction

Teresa Alejandra Trejo-Martin is a prominent inventor based in Union City, CA, known for her significant contributions to the field of pharmaceutical sciences. With a total of seven patents to her name, she has made remarkable strides in the development of compounds that modulate JNK activity, which is crucial in treating various disorders.

Latest Patents

Among her latest patents are the JNK modulators, which include compounds of formula I that effectively modulate JNK. These compounds are designed to inhibit JNK and are particularly relevant in the treatment of JNK-mediated disorders. Additionally, her invention of prodrugs of JNK inhibitors encompasses methods, formulations, and compositions aimed at inhibiting JNK activity. The detailed disclosures in her patents provide insights into the compounds and processes for creating these innovative solutions.

Career Highlights

Throughout her career, Teresa has worked with notable companies, including Roche Palo Alto LLC. Her work has been instrumental in advancing the understanding and treatment of diseases associated with JNK activity. Her innovative approach and dedication to research have positioned her as a key figure in her field.

Collaborations

Teresa has collaborated with esteemed colleagues, including David Michael Goldstein and James Patrick Dunn. These partnerships have further enriched her research and contributed to the success of her inventions.

Conclusion

Teresa Alejandra Trejo-Martin's contributions to the field of pharmaceutical sciences through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in the treatment of JNK-mediated disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…